Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 3073

 

Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 
     

    Article Cited by others

ORIGINAL ARTICLE

Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy

Ajibola S O, Adeyemo T A, Afolabi B B, Akanmu A S

Year : 2016| Volume: 57| Issue : 4 | Page no: 213-216

   This article has been cited by
 
1 The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: an update review
Jiaqi Zhai, Zijian Li, Yue Zhou, Xiuhua Yang
Journal of Reproductive Immunology. 2022; : 103490
[Pubmed]  [Google Scholar] [DOI]
2 Predictive value of the s econd-trimester fibronectin concentration for severe preeclampsia: A prospective nested case–control study in China
Wei Li, Xiaowen Lin, Yuchen Chen, Kun Liu, Weibin Yang, Sifan Zeng, Jing Zhang
Journal of Obstetrics and Gynaecology Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Prevalence of hypertensive disorders of pregnancy and pregnancy outcomes in Sub-Saharan Africa: A systematic review and meta-analysis
Kasiye Shiferaw Gemechu, Nega Assefa, Bizatu Mengistie
Women's Health. 2020; 16: 1745506520
[Pubmed]  [Google Scholar] [DOI]
4 Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia
Flávia Campos Lucena,Eura Martins Lage,Patrícia Gonçalves Teixeira,Alexandre Simões Barbosa,Rejane Diniz,Bashir Lwaleed,André Talvani,Patrícia Nessralla Alpoim,Luiza Oliveira Perucci,Luci Maria SantAna Dusse
Hypertension in Pregnancy. 2019; 38(1): 58
[Pubmed]  [Google Scholar] [DOI]

 

Read this article